The specific mechanism of action between related miRNA and E2F3 has been reported in the literature on hepatocellular carcinoma [46], bladder cancer [47], ovarian cancer [48], LUAD [49], and gastric cancer [50]. This evidence concerns the gene E2F3 and ovarian carcinoma.